No headlines found.
Diebold Nixdorf Reports 2023 Fourth Quarter and Full-Year Financial Results
PRNewswire (Wed, 14-Feb 7:00 AM ET)
Diebold Nixdorf to Conduct 2023 Fourth Quarter, Full-Year Investor Call on Feb. 14
PRNewswire (Thu, 25-Jan 9:00 AM ET)
Diebold Nixdorf Sets Out to Combat Shrink in Retail with New AI-powered Offering
PRNewswire (Thu, 18-Jan 8:04 AM ET)
PRNewswire (Tue, 16-Jan 9:00 AM ET)
Diebold Nixdorf Names Frank Baur as Executive Vice President, Operational Excellence
PRNewswire (Tue, 16-Jan 8:15 AM ET)
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are banking which offers integrated solutions for financial institutions and retail which offers solutions, software, and services which improve the checkout process for retailers.
Diebold Nixdorf trades on the NYSE stock market under the symbol DBD.
As of March 28, 2024, DBD stock price declined to $34.44 with 267,014 million shares trading.
DBD has a beta of 0.61, meaning it tends to be less sensitive to market movements. DBD has a correlation of 0.05 to the broad based SPY ETF.
DBD has a market cap of $1.29 billion. This is considered a Small Cap stock.
The top ETF exchange traded funds that DBD belongs to (by Net Assets): VTI, VXF, SCHA, DFAS, DFAC.
DBD support price is $33.76 and resistance is $35.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DBD stock will trade within this expected range on the day.